151 related articles for article (PubMed ID: 14717966)
1. A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease.
Kremer Hovinga JA; Franco RF; Zago MA; Ten Cate H; Westendorp RG; Reitsma PH
J Thromb Haemost; 2004 Jan; 2(1):54-7. PubMed ID: 14717966
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children.
Emonts M; de Bruijne EL; Guimarães AH; Declerck PJ; Leebeek FW; de Maat MP; Rijken DC; Hazelzet JA; Gils A
J Thromb Haemost; 2008 Feb; 6(2):268-76. PubMed ID: 18021301
[TBL] [Abstract][Full Text] [Related]
3. The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study.
de Bruijne EL; Gils A; Guimarães AH; Dippel DW; Deckers JW; van den Meiracker AH; Poldermans D; Rijken DC; Declerck PJ; de Maat MP; Leebeek FW
J Thromb Haemost; 2009 Jun; 7(6):919-27. PubMed ID: 19323787
[TBL] [Abstract][Full Text] [Related]
4. Plasma thrombin-activatable fibrinolysis inhibitor levels and Thr325Ile polymorphism as a risk marker of myocardial infarction in Egyptian patients.
Kamal HM; Ahmed AS; Fawzy MS; Mohamed FA; Elbaz AA
Acta Cardiol; 2011 Aug; 66(4):483-8. PubMed ID: 21894805
[TBL] [Abstract][Full Text] [Related]
5. Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity.
Hamdy M; Shaheen IA; Khallaf M; Selim YMM
Pediatr Blood Cancer; 2024 Jun; 71(6):e30959. PubMed ID: 38520679
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis.
Mook-Kanamori BB; Valls Serón M; Geldhoff M; Havik SR; van der Ende A; Baas F; van der Poll T; Meijers JC; P Morgan B; Brouwer MC; van de Beek D
J Thromb Haemost; 2015 Nov; 13(11):2076-86. PubMed ID: 26340319
[TBL] [Abstract][Full Text] [Related]
7. Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study.
Fawzy MS; Mohammed EA; Ahmed AS; Fakhr-Eldeen A
Meta Gene; 2015 Jun; 4():73-84. PubMed ID: 25893174
[TBL] [Abstract][Full Text] [Related]
8. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.
Juhan-Vague I; Morange PE; Aubert H; Henry M; Aillaud MF; Alessi MC; Samnegård A; Hawe E; Yudkin J; Margaglione M; Di Minno G; Hamsten A; Humphries SE;
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):867-73. PubMed ID: 12006404
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system.
Zorio E; Castelló R; Falcó C; España F; Osa A; Almenar L; Aznar J; Estellés A
Br J Haematol; 2003 Sep; 122(6):958-65. PubMed ID: 12956767
[TBL] [Abstract][Full Text] [Related]
10. Plasma thrombin-activatable fibrinolysis inhibitor levels and its Thr325Ile polymorphism in breast cancer.
Chengwei X; Xiaoli M; Yuan Z; Li P; Shengjiang W; Chao Y; Yunshan W
Blood Coagul Fibrinolysis; 2013 Oct; 24(7):698-703. PubMed ID: 23624357
[TBL] [Abstract][Full Text] [Related]
11. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
[TBL] [Abstract][Full Text] [Related]
12. Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men.
Meltzer ME; Doggen CJ; de Groot PG; Meijers JC; Rosendaal FR; Lisman T
Haematologica; 2009 Jun; 94(6):811-8. PubMed ID: 19377074
[TBL] [Abstract][Full Text] [Related]
13. Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact.
Frère C; Morange PE; Saut N; Tregouet DA; Grosley M; Beltran J; Juhan-Vague I; Alessi MC
Thromb Haemost; 2005 Aug; 94(2):373-9. PubMed ID: 16113828
[TBL] [Abstract][Full Text] [Related]
14. Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.
Brouwers GJ; Leebeek FW; Tanck MW; Wouter Jukema J; Kluft C; de Maat MP
Thromb Haemost; 2003 Jul; 90(1):92-100. PubMed ID: 12876631
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis].
González FJ; Caturla JM; Fernández M; Carrasco R; Marco P; Sánchez J; Benlloch S
Med Intensiva; 2010 Nov; 34(8):513-22. PubMed ID: 20627371
[TBL] [Abstract][Full Text] [Related]
16. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.
Stanne TM; Olsson M; Lorentzen E; Pedersen A; Gummesson A; Gils A; Jood K; Engström G; Melander O; Declerck PJ; Jern C
Thromb Haemost; 2018 Feb; 118(2):298-308. PubMed ID: 29378355
[TBL] [Abstract][Full Text] [Related]
17. A new functional assay of thrombin activatable fibrinolysis inhibitor.
Guimarães AH; Bertina RM; Rijken DC
J Thromb Haemost; 2005 Jun; 3(6):1284-92. PubMed ID: 15946219
[TBL] [Abstract][Full Text] [Related]
18. High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke.
Leebeek FW; Goor MP; Guimaraes AH; Brouwers GJ; Maat MP; Dippel DW; Rijken DC
J Thromb Haemost; 2005 Oct; 3(10):2211-8. PubMed ID: 16092924
[TBL] [Abstract][Full Text] [Related]
19. Generation of a stable thrombin-activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation.
Zhou X; Declerck PJ
J Thromb Haemost; 2015 Jun; 13(6):1084-9. PubMed ID: 25773535
[TBL] [Abstract][Full Text] [Related]
20. TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study.
Morange PE; Tregouet DA; Frere C; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Cambien F; Tiret L; Juhan-Vague I;
J Thromb Haemost; 2005 Jul; 3(7):1503-10. PubMed ID: 15978108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
